FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Resources - All Kinds, Realm US

21,578 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

By Authority

 

Start Prev Rows 15200 - 15400 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthUsage #
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1247.94.jsonSocial Connection Proceduresactive2024-06hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1247.95.jsonSocial Connection Service Requestsactive2024-06hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1247.97.jsonIntimate Partner Violence Proceduresactive2024-06hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1247.98.jsonIntimate Partner Violence Service Requestsactive2024-06hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1247.280.jsonToxic Stress Proceduresactive2025-07hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1247.281.jsonRacism Service Requestsactive2025-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1247.291.jsonRacism Proceduresactive2025-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1247.292.jsonToxic Stress Service Requestsactive2025-07hl7
fhir.cdc.opioid-cds-r4R4ValueSet/ValueSet-amphetamines-class-medications.jsonAmphetamine class medicationsactive2025-02hl72
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.965.jsonAmplification and Extraction Kitactive2008-01
hl7.fhir.us.covid19libraryR4ValueSet/ValueSet-covid-19-severity-value-set.jsonCOVID-19 Signs and Symptoms Severity Value Setactive2022-07hl7
hl7.fhir.us.breastcancerR3ValueSet/ValueSet-oncology-TumorMarginDescriptionVS.jsonBC TumorMarginDescriptionVS ValueSetdraft2018-08hl72
hl7.fhir.us.breastcancerR3ValueSet/ValueSet-oncology-Ki-67NuclearAntigenVS.jsonBC Ki-67NuclearAntigenVS ValueSetdraft2018-08hl72
signal.core.r4R4ValueSet/valueset-service-request-order-detail.jsonService Request Order Details Codesdraft1oo2019-10hl7
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7613.jsonJob Supervisory Level or Pay Grade (ODH)active2020-012
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7652.jsonMailing Address Indicator (NCHS)active2017-01
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.22.5.306.jsonInfectious Diseaseactive2024-06hl7
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3124.jsonBody Region (Tetanus)active2008-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7189.jsonSpecimen Source (STD)active2020-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7554.jsonSpecimen Collection Site AST (STD)active2017-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3285.jsonAnatomical Entity (Body Site)active2009-01
hl7.fhir.us.breastcancerR3ValueSet/ValueSet-cimi-element-AnatomicalDirectionVS.jsonBC AnatomicalDirectionVS ValueSetdraft2018-08hl77
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.1074.jsonAnimalactive2010-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3072.jsonAnimal Type (FDD)active2008-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7793.jsonLikely Contact (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3067.jsonVirus Variant Type (Animal Rabies)active2008-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3068.jsonAnimal Species (Animal Rabies)active2008-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7971.jsonAnimal Type (Brucellosis)active2020-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7967.jsonAnimal Type (Leptospirosis)active2020-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7999.jsonAnimal Type (Anthrax)active2020-01
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1235.21.jsonAnnual Physical CPT CN5active2023-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1235.23.jsonAnnual Physical CPT for Tax Pair CN5active2024-06hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1235.30.jsonAnnual Physical Codes for Tax Pair CN5active2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1235.22.jsonAnnual Physical HCPCS CN5active2023-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1235.17.jsonAnnual Physical ICD10 CN5active2024-06hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1235.16.jsonAnnual Physical ICD9 CN5active2023-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1235.24.jsonAnnual Physical ICD9 for Tax Pair CN5active2024-06hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1235.18.jsonAnnual Physical SNOMED CN5active2023-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1235.19.jsonAnnual Physical Taxonomy CN5active2024-06hl7
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3125.jsonCase Classification Exposure Sourceactive2008-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.8013.jsonExposure Source (Anthrax)active2020-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3089.jsonInterview Statusactive2008-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3167.jsonTherapy Extended Reason (TB)active2008-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3074.jsonCase Traced to Carrieractive2008-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3119.jsonAcute Convalescent IgG Difference (VPD)active2008-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3166.jsonCause of Death Related to TBactive2008-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7620.jsonAntacids (FDD)active2017-01
hl7.fhir.us.breast-radiologyR4ValueSet/ValueSet-rde1559-depth.jsonRDE1559 Depthdraft2022-12hl71
hl7.fhir.us.ecrR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.481-example.jsonAnthrax (Tests for Bacillis anthracis Antibody)informativepher2025-12hl72
hl7.fhir.us.ecrR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.480-example.jsonAnthrax (Tests for Bacillis anthracis Antigen)informativepher2025-12hl72
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3212.jsonSigns and Symptoms (Anthrax)active2009-01
hl7.fhir.us.ecrR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1082-example.jsonAnthrax Vaccine (RXNORM)informativepher2025-12hl71
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3220.jsonDisease Type (Anthrax)active2009-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3207.jsonLab Test Result Name (Anthrax)active2009-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3216.jsonMedication Treatment (Anthrax)active2009-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3317.jsonAntimicrobial Susceptibility Test Method (IPD)active2010-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3316.jsonAntimicrobial Agent (IPD)active2010-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.8036.jsonAntibiotic Dose Units (Brucellosis)active2021-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7693.jsonAntibiotic Received (RIBD)active2021-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3120.jsonAntibiotic Received (Pertussis)active2015-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7619.jsonAntibiotics (FDD)active2018-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7553.jsonSpecimen Type AST (STD)active2017-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7557.jsonSusceptibility Test Interpretation (STD)active2017-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7704.jsonSusceptibility Interpretation (RIBD)active2019-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7701.jsonAR Test Method (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7556.jsonSusceptibility Test Method (STD)active2017-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7559.jsonSusceptibility Test Result Quantitative (STD)active2017-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7558.jsonSusceptibility Test Result Units (STD)active2017-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7555.jsonSusceptibility Test Type (STD)active2017-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7700.jsonAR Agent (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.8005.jsonAntimicrobials (Anthrax)active2020-01
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.45.jsonEndometrial Cancer ICD9active2023-11hl71
fhir.cdc.opioid-cds-r4R4ValueSet/ValueSet-conditions-documenting-substance-misuse.jsonConditions documenting substance misuseactive2025-04hl7
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.1045.jsonSpecimen Riskactive2008-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.6038.jsonMorphology of Neoplasms ICD-9-CMactive2012-01
hl7.fhir.us.codex-radiation-therapyR4ValueSet/ValueSet-codexrt-brachytherapy-applicator-type-vs.jsonBrachytherapy Applicator Type Value Settrial-usecgp2026-02hl71
fhir.kenyaCoreIGR4ValueSet/ValueSet-approval-status-vs.jsonApproval Status Value Setdraft2026-01hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.1.11.20.2.7.jsonNutritional Statusactive2025-01hl73
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.326.jsonArboviral Disease [Other] (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.575.jsonArboviral Disease [Other] (Tests for Arbovirus [Other] Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.576.jsonArboviral Disease [Other] (Tests for Arbovirus [Other] Antigen)active2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.577.jsonArboviral Disease [Other] (Tests for Arbovirus [Other] IgM Antibody)active2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.578.jsonArboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Quantitative])active2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.579.jsonArboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Qualitative])active2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.580.jsonArboviral Disease [Other] (Organism or Substance in Lab Results)active2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.963.jsonArboviral Disease [Other] (Disorders) (SNOMED)active2025-02hl7
hl7.fhir.us.ecrR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1508-example.jsonArsenic Exposure and Toxicity (Disorders) (ICD10CM)informativepher2025-12hl71
hl7.fhir.us.ecrR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1507-example.jsonArsenic Exposure and Toxicity (Disorders) (SNOMED)informativepher2025-12hl71
hl7.fhir.us.registry-protocolsR4ValueSet/ValueSet-ArterialAccessSite.jsonArterial Access Siteactivecic2023-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1186.7.jsonCommon substances for allergy and intolerance documentationactive2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1186.8.jsonCommon substances for allergy and intolerance documentation including refutationsactive2024-06hl73
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.39.jsonPersonal Health Goal Options Groupingactive2025-03hl7
ca.on.oh-dhdrR4ValueSet/DrugServiceCoverage.jsonDrug Service Coverageactivehl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.88.12.80.60.jsonSocial History Type (SCT)active2025-04hl72
hl7.fhir.us.ndhR4ValueSet/ValueSet-NdhAssociatedServersTypeVS.jsonAssociated Servers Type Value Settrial-use4pa2026-03hl72
hl7.fhir.us.breast-radiologyR4ValueSet/ValueSet-AsymmetryAbnormalityTypeVS.jsonAsymmetry Abnormality Type ValueSetactive2022-12hl71
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7140.jsonAutopsy Planned (NCHS)active2014-01
fhir.nhs.uk.stu3.assetsR3ValueSet/ValueSet-eRS-AvailabilityStatus-1.jsoneRS Availability Statusactive2024-08hl71
fhir.ca-bc.clientR4ValueSet/ValueSet-bc-address-validation-value-set.jsonBC Address Validation Value Setactive2025-02hl71
fhir.ca-bc.clientR4ValueSet/ValueSet-bc-contact-point-system-value-set.jsonBC Contact Point System Value Setactive2025-02hl72
fhir.ca-bc.clientR4ValueSet/ValueSet-bc-contact-point-use-value-set.jsonBC Contact Point Use Value Setactive2025-02hl72
fhir.ca-bc.providerR4ValueSet/ValueSet-bc-expertise-value-set.jsonBC Expertise Value Setactive2025-02hl71
fhir.ca-bc.clientR4ValueSet/ValueSet-bc-identifier-status-value-set.jsonBC Identifier Status Value Setactive2025-02hl71
fhir.ca-bc.providerR4ValueSet/ValueSet-bc-language-value-set.jsonBC Language Value Setactive2025-02hl71
fhir.ca-bc.clientR4ValueSet/ValueSet-bc-merge-status-value-set.jsonBC Merge Status Value Setactive2025-02hl71
fhir.ca-bc.clientR4ValueSet/ValueSet-bc-name-use-value-set.jsonBC Name Use value set.active2025-02hl73
fhir.ca-bc.providerR4ValueSet/ValueSet-bc-organization-role-value-set.jsonBC Organization Role Code Value Setactive2025-02hl71
fhir.ca-bc.providerR4ValueSet/ValueSet-bc-practitioner-role-value-set.jsonBC Practitioner Role Code Value Setactive2025-02hl71
fhir.ca-bc.providerR4ValueSet/ValueSet-bc-address-validation-status-value-set.jsonBC Address Validation Status Value Setactive2025-02hl71
fhir.ca-bc.providerR4ValueSet/ValueSet-bc-communication-purpose-value-set.jsonBC Communication Purpose Value Setactive2025-02hl71
fhir.ca-bc.providerR4ValueSet/ValueSet-bc-end-reason-value-set.jsonBC End Reason Value Setactive2025-02hl71
fhir.ca-bc.providerR4ValueSet/ValueSet-bc-relationship-type-value-set.jsonBC Relationship Type Value Setactive2025-02hl7
fhir.ca-bc.providerR4ValueSet/ValueSet-bc-license-status-class-value-set.jsonBC License Status Class Value Setactive2025-02hl71
fhir.ca-bc.providerR4ValueSet/ValueSet-bc-license-status-reason-value-set.jsonBC License Status Reason Value Setactive2025-02hl71
fhir.ca-bc.providerR4ValueSet/ValueSet-bc-license-status-value-set.jsonBC License Status Value Setactive2025-02hl71
fhir.ca-bc.providerR4ValueSet/ValueSet-bc-qualification-value-set.jsonBC Practitioner Qualification Value Setactive2025-02hl71
hl7.fhir.us.bserR4ValueSet/ValueSet-TaskBusinessStatusVS.jsonTask Business Status VSdraft2025-04hl71
hl7.fhir.us.bser.r4R4ValueSet/ValueSet-BSeR-TelcomCommunicationPreferencesVS.jsonBSeR Telcom Communication Preferences VSdraft2023-07hl71
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3318.jsonBacterial Infection Syndrome (IPD)active2010-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7686.jsonMicroorganism (RIBD)active2019-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3405.jsonRace Category including Unknownactive2011-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7204.jsonRace Category including Refusedactive2013-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7205.jsonRace Category including Null Flavoractive2013-01
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1287.jsonSeptic shockactive2025-06hl7
hl7.fhir.us.davinci-drug-formularyR4ValueSet/ValueSet-BenefitCostTypeVS.jsonBenefit type of costtrial-usephx2025-02hl71
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7903.jsonGC beta-lactamase result (ARLN)active2019-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3323.jsonBirth Outcome (Rubella)active2010-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7223.jsonBirth Status (NND)active2020-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3224.jsonBlood or body fluid exposure eventactive2009-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3225.jsonBlood or body fluid exposure frequencyactive2009-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7707.jsonBlood Type (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.1067.jsonBody Substanceactive2010-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3117.jsonBody Site (FDD)active2008-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7826.jsonSpecimen Source Site (VPD)active2017-12
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.967.jsonBody siteactive2019-12
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3131.jsonLab Result (Pertussis)active2008-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3073.jsonBotulinum Toxin Type (FDD)active2008-01
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1237.18.jsonMedication Prescribable Brand Nameactive2021-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.88.12.80.16.jsonMedication Brand Nameactive2024-06hl7
hl7.fhir.us.breast-radiologyR4ValueSet/ValueSet-BreastAssessmentCategoryVS.jsonBreast Assessment Category ValueSetactive2022-12hl716
hl7.fhir.us.breast-radiologyR4ValueSet/ValueSet-rde1560-breast-body-landmark.jsonRDE1560 Breast body landmarkdraft2022-12hl71
hl7.fhir.us.breast-radiologyR4ValueSet/ValueSet-rde1557-side.jsonRDE1557 Sidedraft2022-12hl71
hl7.fhir.us.directory-queryR4ValueSet/ValueSet-HealthcareServiceCategoryVS.jsonHealthcare Service Category Value Setactive2022-12hl71
hl7.fhir.us.davinci-pdex-plan-netR4ValueSet/ValueSet-HealthcareServiceCategoryVS.jsonHealthcare Service CategoryVStrial-usefm2025-02hl71
hl7.fhir.us.ndhR4ValueSet/ValueSet-HealthcareServiceCategoryVS.jsonHealthcare Service Category Value Settrial-use4pa2026-03hl72
signal.core.r4R4ValueSet/valueset-healthcare-service-category.jsonSignal Healthcare Service Categorydraft1pahl72
fhir.cdc.opioid-cds-r4R4ValueSet/ValueSet-opioid-treatment-assessment-procedure.jsonOpioid treatment assessment procedureactive2023-05hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1010.1.jsonSubstance Reactant for Intoleranceactive2024-06hl72
hl7.fhir.us.mcodeR4ValueSet/ValueSet-mcode-lymphoma-stage-bulky-modifier-vs.jsonLymphoma Stage Bulky Modifier Value Setactivecic2025-02hl71
hl7.fhir.us.vdorR4ValueSet/ValueSet-vdor-bystanders-present-vs.jsonVDOR Bystander(s) Presentinformativepher2026-03hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.88.12.3221.8.11.jsonMedication Product Formactive2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.114.jsonHematocrit Lab Testactive2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.117.jsonPotassium Lab Testactive2023-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.119.jsonSodium Lab Testactive2022-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.127.jsonPlatelet Count Lab Testactive2023-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.129.jsonWhite Blood Cells Count Lab Testactive2023-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.134.jsonGlucose Lab Testactive2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.139.jsonBicarbonate Lab Testactive2023-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.152.jsonBody Temperatureactive2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.159.jsonBody Weightactive2023-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1104.10.jsonMedicare FFS Payeractive2023-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1104.12.jsonMedicare Advantage Payeractive2023-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.666.5.2363.jsonCreatinine Lab Testactive2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.151.jsonOxygen Saturation by Pulse Oximetryactive2023-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.36.jsonAll Metastatic Sitesactive2023-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.43.jsonBreast Canceractive2023-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.44.jsonBreast Canceractive2023-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.15.jsonAll Metastatic Sitesactive2023-10hl73
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.35.jsonAll Metastatic Sitesactive2023-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.39.jsonLocoregional Breast Canceractive2023-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.38.jsonLocoregional Breast Canceractive2023-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.37.jsonLocoregional Breast Canceractive2023-10hl71
hl7.fhir.us.davinci-pctR4ValueSet/ValueSet-PCTGFECMSPOS.jsonPCT GFE CMS Place of Service Value Settrial-use2fm2026-03hl72
signal.core.r4R4ValueSet/valueset-place-of-service.jsonPlace Of Servicedraft1pahl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.229.jsonCOVID19 Related Disease, Test, or Exposureactive2021-03hl7
hl7.fhir.us.ecrR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1223-example.jsonCOVID_19 (Tests for SARS_CoV_2 by Culture and Identification Method)informativepher2025-12hl71
hl7.fhir.us.davinci-pctR4ValueSet/ValueSet-USClaimMedicalProductOrServiceCodes.jsonClaim Medical Product or Service Value Settrial-use2fm2026-03hl75
hl7.fhir.us.davinci-pctR4ValueSet/ValueSet-PCTGFEItemCptHcpcsVS.jsonPCT GFE Item CPT - HCPCS Value Settrial-use2fm2026-03hl73
hl7.fhir.us.icsr-ae-reportingR4ValueSet/ValueSet-COVID19VaccineCodeVS.jsonCOVID-19 Vaccine Codesdraft2023-08hl71
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.996.jsonHistory Source (CRA)active2008-01
hl7.fhir.us.registry-protocolsR4ValueSet/ValueSet-CardiacCTA.jsonCTA Heart and Coronary arteriesactivecic2023-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.88.12.80.22.jsonCVX Vaccines Administered Complete Setactive2024-06hl7
hl7.fhir.us.icsr-ae-reportingR4ValueSet/ValueSet-VaccineCodeVS.jsonVaccine Codesdraft2023-08hl71
hl7.fhir.us.icsr-ae-reportingR4ValueSet/ValueSet-InfluenzaVaccineCodeVS.jsonInfluenza Vaccine Codesdraft2023-08hl71
hl7.fhir.us.breast-radiologyR4ValueSet/ValueSet-CalcificationDistributionVS.jsonCalcificationDistribution ValueSetactive2022-12hl7
hl7.fhir.us.ecrR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1184-example.jsonCalifornia Serogroup Virus Diseases (Tests for California Serogroup Virus Antibody [Quantitative])informativepher2025-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1189.jsonCalifornia Serogroup Virus Diseases (Tests for California Serogroup Virus Antibody [Qualitative])active2023-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.16.jsonAll Metastatic Sitesactive2023-10hl73
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.5.jsonUnstageable Hematologic Disorders and Neoplasmsactive2025-10hl7
fhir.cdc.opioid-cds-r4R4ValueSet/ValueSet-cannabinoid-urine-drug-screening-tests.jsonCannabinoid class urine drug screeningactive2023-05hl71
hl7.fhir.us.registry-protocolsR4ValueSet/ValueSet-CardiacCTAResults.jsonCardiac CTA Resultsactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/ValueSet-CardiacInstabilityType.jsonCardiac Instability Typeactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7272.jsonCase Notification MMG Version (NND)active2015-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7271.jsonCase Notification Specification Version (NND)active2015-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3138.jsonRelationship (VPD)active2008-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7366.jsonRelationship (NND)active2020-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.3158.jsonCase Count Status (TB)active2018-01
us.cdc.phinvadsR4ValueSet/ValueSet-2.16.840.1.114222.4.11.7957.jsonRelationship (Hansen)active2020-01
hl7.fhir.us.davinci-crdR4ValueSet/ValueSet-cs-categories.jsonCRD Conformance Statement Categoriestrial-use4fm2026-03hl7
hl7.fhir.us.davinci-dtrR4ValueSet/ValueSet-cs-categories.jsonConformance Statement Categoriestrial-use2cds2026-04hl7